{"id":5823,"date":"2017-07-25T11:55:46","date_gmt":"2017-07-25T11:55:46","guid":{"rendered":"http:\/\/cobrca.org\/?page_id=5823"},"modified":"2024-08-19T10:52:20","modified_gmt":"2024-08-19T10:52:20","slug":"veracyte-symposium","status":"publish","type":"page","link":"https:\/\/cobrca.org\/cobrca2024\/veracyte-symposium\/","title":{"rendered":"Veracyte Symposium"},"content":{"rendered":"

Breakfast Industry Symposium:
\n<\/strong>What is the true utility of genomic testing in Early Breast Cancer?
\nA closer look at intrinsic subtyping and Prosigna
\nSupported by Ve<\/em><\/strong><\/span>racyte
\n\"\"
\n<\/em><\/strong><\/span><\/h3>\n

Thursday, September 12, 2024
\n07:30-08:30
\nHALL A
\n<\/strong><\/span>Light refreshments will be served prior to the session from 7:00<\/em><\/p>\n\n\n\n\n\n\n
Chairperson<\/strong><\/td>\nLesley Fallowfield,<\/strong> Sussex,<\/em> UK<\/em><\/td>\n<\/tr>\n
07:30-07:50<\/strong><\/td>\nThe development of and clinical utility of PAM50 and intrinsic subtyping, and a comparison of the available technologies
\nMatthew J. Ellis, <\/strong>Houston, TX, USA<\/em><\/td>\n<\/tr>\n
07:50-08:10<\/strong><\/td>\nHow will the OPTIMA trial answer many of the outstanding questions around the utility of genomic testing? What effect will the implementation of PREDICT 3 have on the use of GEP testing?
\n<\/em>Stuart McIntosh, <\/strong>Belfast, UK<\/em><\/td>\n<\/tr>\n
08:10-08:30<\/strong><\/td>\nHow well do healthcare professionals and patients understand the information provided by genomic test reports?
\nLesley Fallowfield,<\/strong> Sussex,<\/em> UK<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Breakfast Industry Symposium: What is the true utility of genomic testing in Early Breast Cancer? A closer look at intrinsic subtyping and Prosigna Supported by Veracyte [\u2026]<\/span><\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5823","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5823"}],"collection":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/comments?post=5823"}],"version-history":[{"count":13,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5823\/revisions"}],"predecessor-version":[{"id":10190,"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/pages\/5823\/revisions\/10190"}],"wp:attachment":[{"href":"https:\/\/cobrca.org\/cobrca2024\/wp-json\/wp\/v2\/media?parent=5823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}